Tsubota Laboratory Incorporated
JPX: 4890.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Kazuo Tsubota
- Employees
- 7
- Headquarters
- Tokyo, Japan
- IPO year
- 2022
- Market cap
- ¥7.7B
- Website
- https://www.tsubota-lab.com
Loading 4890…
Loading profile data…Frequently asked questions about 4890
What does Tsubota Laboratory Incorporated (4890.T) do?
Tsubota Laboratory Incorporated engages in the research and development of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, and presbyopia. The company was incorporated in 2012 and is based in Tokyo, Japan.
Where does 4890.T trade?
Tsubota Laboratory Incorporated (4890.T) trades on the Tokyo Stock Exchange.
What sector is 4890.T in?
Tsubota Laboratory Incorporated (4890.T) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Tsubota Laboratory Incorporated?
Kazuo Tsubota is the chief executive officer of Tsubota Laboratory Incorporated (4890.T).
Where is Tsubota Laboratory Incorporated headquartered?
Tsubota Laboratory Incorporated is headquartered in Japan.
Does 4890.T pay a dividend?
Tsubota Laboratory Incorporated (4890.T) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 4890.T go public?
Tsubota Laboratory Incorporated (4890.T) completed its initial public offering in 2022.